Skip to main content

Advertisement

SpringerLink
Log in

Safe and effective methylphenidate therapy in a pediatric patient with glaucoma

  • Case Report
  • Published:
ADHD Attention Deficit and Hyperactivity Disorders

Abstract

Stimulant medications used as first-line treatment in attention deficit hyperactivity disorder (ADHD) are contraindicated in patients with glaucoma. We present the first reported case of using methylphenidate therapy to safely and effectively treat ADHD in a pediatric patient with glaucoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • American Academy of Pediatrics [AAP] Subcommittee on Attention-Deficit Hyperactivity Disorder and Committee on Quality Improvement (2001) Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics 108(4):1033–1044

    Article  Google Scholar 

  • Aponte EP, Diehl N, Mohney BG (2010) Incidence and clinical characteristics of childhood glaucoma: a population-based study. Arch Ophthalmol 28(4):478–482

    Article  Google Scholar 

  • Bartik B, Harmon G, Kaplan F (1997) Use of methylphenidate therapy in a patient with glaucoma and attention-deficit hyperactivity disorder: a clinical dilemma. Arch Gen Psychiatry 54:188–189

    Article  Google Scholar 

  • Garnock-Jones KP, Keating GM (2009) Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents. Paediatr Drugs 11:203–226

    Article  PubMed  Google Scholar 

  • Hieble JP, Ruffolo RR Jr (1997) Recent advances in the identification of alpha1- and alpha-2-adrenoceptor subtypes: therapeutic implications. Exp Opin Investig Drugs 6(4):367–387

    Article  CAS  Google Scholar 

  • Lu CK, Kuang TM, Chou JC (2006) Methylphenidate (Ritalin)-associated cataract and glaucoma. J Chin Med Assoc 69:589–590

    Article  PubMed  CAS  Google Scholar 

  • Pliszka S (2007) Practice parameter for the assessment and treatment of children and adolescents with attention- deficit/hyperactivity disorder. J Am Acad Adolesc Psychiatry 46(7):894–921

    Article  Google Scholar 

  • Rappley M (2005) Attention deficit hyperactivity disorder. N Engl J Med 352:165–173

    Article  PubMed  CAS  Google Scholar 

  • Reid WH, Blouin P, Schermer M (1976) A review of psychotropic medications and the glaucomas. Int Pharmacopsychiatry 11(3):163–174

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Joan C. Edwards School of Medicine at Marshall University, 1600 Medical Center Drive, Huntington, WV, 25701, USA

    Heidi Lewis & James Lewis

Authors
  1. Heidi Lewis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James Lewis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Heidi Lewis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lewis, H., Lewis, J. Safe and effective methylphenidate therapy in a pediatric patient with glaucoma. ADHD Atten Def Hyp Disord 4, 37–39 (2012). https://doi.org/10.1007/s12402-012-0071-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12402-012-0071-9

Keywords

Search

Navigation